CVE:VMD - Viemed Healthcare Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: C$0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
C$4.95
▼ -0.1 (-1.98%)

This chart shows the closing price for VMD by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Viemed Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VMD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VMD

Analyst Price Target is C$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Viemed Healthcare in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a -100.00% upside from the last price of C$4.95.

This chart shows the closing price for VMD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Viemed Healthcare. This rating has held steady since April 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/25/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/23/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/21/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/21/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/20/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/18/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/18/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/24/2019Acumen CapitalSet Price TargetBuyC$12.00
5/8/2018Beacon SecuritiesReiterated RatingBuy
(Data available from 10/18/2016 forward)

News Sentiment Rating

0.22 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/22/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/21/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/21/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/20/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/20/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/19/2021
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/18/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/18/2021

Current Sentiment

  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.

Viemed Healthcare

Viemed Healthcare, Inc., through its subsidiaries, provides in-home health care solutions in the United States. It offers respiratory services and related equipment, including non-invasive ventilators, positive airway pressure machines, and oxygen units, as well as services of respiratory therapists. The company also provides in-home sleep apnea testing to determine the existence of sleep apnea at home. In addition, it leases equipment, including non-invasive ventilators, bi-level devices and CPaP, percussion vests, and various supplies and peripheral equipment, as well as sells medical equipment and patient monitoring services. Further, the company provides therapy, education, and counseling to patients in their homes using technology. Viemed Healthcare, Inc. is headquartered in Lafayette, Louisiana.
Read More

Today's Range

Now: C$4.95
Low: C$4.84
High: C$5.05

50 Day Range

MA: C$4.95
Low: C$4.95
High: C$4.95

52 Week Range

Now: C$4.95
Low: C$1.65
High: C$5.34

Volume

91,383 shs

Average Volume

197,608 shs

Market Capitalization

C$187.65 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Viemed Healthcare?

The following sell-side analysts have issued reports on Viemed Healthcare in the last twelve months:
View the latest analyst ratings for VMD.

What is the current price target for Viemed Healthcare?

0 Wall Street analysts have set twelve-month price targets for Viemed Healthcare in the last year. has the lowest price target set, forecasting a price of C$10,000,000.00 for Viemed Healthcare in the next year.
View the latest price targets for VMD.

What is the current consensus analyst rating for Viemed Healthcare?

Viemed Healthcare currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for VMD.